Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Preferred Stock Liabilities (2019 - 2021)

Historic Preferred Stock Liabilities for Strata Critical Medical (SRTA) over the last 3 years, with Q1 2021 value amounting to $225.0 million.

  • Strata Critical Medical's Preferred Stock Liabilities fell 1454.49% to $225.0 million in Q1 2021 from the same period last year, while for Mar 2021 it was $225.0 million, marking a year-over-year decrease of 1454.49%. This contributed to the annual value of $226.1 million for FY2020, which is N/A changed from last year.
  • As of Q1 2021, Strata Critical Medical's Preferred Stock Liabilities stood at $225.0 million, which was down 1454.49% from $226.1 million recorded in Q4 2020.
  • Over the past 5 years, Strata Critical Medical's Preferred Stock Liabilities peaked at $263.3 million during Q1 2020, and registered a low of $225.0 million during Q1 2021.
  • In the last 3 years, Strata Critical Medical's Preferred Stock Liabilities had a median value of $262.0 million in 2019 and averaged $249.9 million.
  • Its Preferred Stock Liabilities has fluctuated over the past 5 years, first soared by 43.99% in 2020, then plummeted by 1454.49% in 2021.
  • Quarter analysis of 3 years shows Strata Critical Medical's Preferred Stock Liabilities stood at $246.6 million in 2019, then fell by 8.32% to $226.1 million in 2020, then fell by 0.48% to $225.0 million in 2021.
  • Its Preferred Stock Liabilities was $225.0 million in Q1 2021, compared to $226.1 million in Q4 2020 and $263.2 million in Q3 2020.